BTK-IN-39
BTK-IN-39 (0204) is a PROTAC target protein ligand that can be used to synthesize PROTAC BTK Degrader-11 (HY-159947) [1].
Product Specifications
CAS Number
[2736510-62-4]
UNSPSC
12352005
Target
Ligands for Target Protein for PROTAC
Type
Reference compound
Related Pathways
PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/btk-in-39.html
Smiles
CC1=C([C@@H](C)NC(C2=NC(C(C)(C)C)=NO2)=O)C=CC(C3=C4C(NC(C5=CN=C(N6CCN(CC6)C(OC(C)(C)C)=O)C=C5)=C4)=NC=N3)=C1
Molecular Formula
C36H43N9O4
Molecular Weight
665.78
References & Citations
[1]Haitao Wang, et al. Degradation of bruton's tyrosine kinase (btk) by conjugation of btk inhibitors with e3 ligase ligand and methods of us. WO2021219070A1. 2021-11-04.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RC225283L3V 200 µL
RABL2B (NM_001130919) Human Tagged ORF Clone Lentiviral Particle
Ask
View Details 
S1010-84E 50 µg
SGK1 (Serum/Glucocorticoid Regulated Kinase 1, Serine/Threonine Protein Kinase SGK1) discontinued
Ask
View Details 
C0621 96 Tests
Calcium/Calmodulin Dependent Protein Kinase type II subunit delta (CAMK2D) Rabbit ELISA Kit
Ask
View Details